Sandy Lee

Thank you, Mr. Speaker. The program continues. We continue to support the program. Thank you, Mr. Speaker.

I am not aware of that plan. If there were, I would let the Member know.

Thank you, Mr. Speaker. As we have discussed on many different occasions in standing committee and in health information dialogue and in the health community, deficit is a common issue everywhere in Canada. Every jurisdiction is faced with rising health care costs, rising health care services, rising drug costs, equipment costs, labour costs and the demand of service. NWT is no exception.

Stanton Territorial Health Authority is a territorial body. Their deficit is not Stanton’s deficit per se, but it is a system deficit. Dr. Corkal, who is the medical director, and the CEO, Kay Louis, and the...

I’ll have to get the details, but I would venture to guess that actual service of that specialist that we would have to pay in wherever place that they go would be as high, if not higher, than the medical travel and related expenses. There is a formula for the services like neurologists and inter-jurisdictional billing and such. So we would be paying for that specialist in Edmonton or wherever, while at the same time we are paying for our in-house specialist.

Specialists are, as you know, quite, I don’t want to say expensive, but we pay a lot of money to have somebody like a neurologist. We...

Thank you, Mr. Speaker. I do appreciate the need to make this sort of process as smooth and seamless as possible for the patient. I am aware that one of the patients in Hay River we did approve the travel, but we did give notice that for next year she would have to travel to a neurologist in Yellowknife. Also, I will work with the department to make sure that we review the files and see that if there is going to be a change in specialists that they need to see, that we give them as much notice as possible. Thank you.

I would appreciate getting more information from the Member, perhaps, on the specific situation. It’s case by case and it’s depending on the person and what facility they are in. We pay for medical escorts, but we do not have a budget to pay for somebody to visit anybody in long-term care at any time. It’s a question that we get asked all the time, so I would need what facility they are in and what condition and under what circumstances they were asked to have support. If they’re indigent, if they’re on income security, sometimes we’ve covered those. Sometimes they’re covered under employer’s...

Thank you. We would be part of or we could sign up to be a part of national research when the clinical trials are ready to proceed. Mr. Speaker, my understanding is any clinical trials or procedures like this have a very set objective process that scientists and doctors follow. They have to be random, they have to be double blinded and it has to be safe. In all of the jurisdictions there are lots of researchers at different university settings that are studying this issue and right now. The information is that science does not indicate that we could do this clinical trial safely. But NWT...

Yes, we do, especially with the opening of the Territorial Dementia Centre and the Hay River Assisted Living Facility. We did review clients outside of the jurisdiction, our clients in other jurisdictions, to see if they can be moved.

Territorial Admissions Committee are administrators who review the files to see where our clients should be best placed within the Territory. Questions about how do they get paid to be moved would be on a case-by-case basis. Thank you.

Thank you, Mr. Speaker. The Government of the Northwest Territories and the Department of Health and Social Services is on board with all of the other jurisdictions in Canada. All of the Ministers of Health have agreed that we are supportive of this treatment going forward once there is scientific evidence that would take us to the next level. All provinces and territories have agreed that we will work together and work with the scientists to be ready when the scientific evidence shows that this procedure is ready for clinical trial. Thank you, Mr. Speaker.

Mr. Speaker, I take the Member’s point and he’s asking questions and making suggestions. He brought this issue to me yesterday. I’m committing to the Member to get the information from the authority as to exactly what their plans are. They may have a very good explanation as to the move and what other plans that are part of this move. So I think it’s important for us to get a full picture of if there are any other related issues surrounding that, and then when we get the full picture, of course, I’ll welcome the Member’s input on what we can do better or do differently or anything else. Thank...